Literature DB >> 6313390

Hypotensive activity of calcium entry blockers in rats. Relationship with depression of alpha 2-adrenoceptor-mediated vasopressor responses.

J C Van Meel, P B Timmermans, P A Van Zwieten.   

Abstract

The hypotensive activity of a series of calcium entry blockers and various other vasodilators was quantified in pentobarbitone-anesthetized rats. Hypotensive activity was correlated linearly with the potency of these vasoactive agents to depress alpha 2-adrenoceptor-induced pressor responses in pithed rats. However, vasodilatation as such also influenced alpha 2-adrenoceptor-mediated vasoconstrictor processes. For this reason, the depressive action of the vasodilating compounds on alpha 2-adrenoceptor-induced pressor effects was also determined during vasopressin infusion, which counteracted the vasodilatation induced by the vasoactive compounds. It was found that the hypotensive activity exerted by the calcium entry blockers was directly related with their inhibitory activity to depress alpha 2-pressor responses. This relationship was not observed for the other vasodilators. The results provide further evidence for the hypothesis that vasodilatation induced by calcium entry blockers is caused by the selective impairment of that part of the vascular tone which is maintained by vascular postjunctional alpha 2-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6313390     DOI: 10.1016/0014-2999(83)90104-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 2.  Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.

Authors:  H A Friedel; R N Brogden
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

3.  Calcium channel antagonists: pharmacological considerations.

Authors:  D Rampe; C M Su; F Yousif; D J Triggle
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

4.  Studies on the effects of felodipine on the vascular resistance and reactivity in pentobarbital anesthetized dogs.

Authors:  B S Jandhyala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-06       Impact factor: 3.000

5.  Calcium channel blockers and the emergency care kit in the dental office.

Authors:  T Kosmac
Journal:  Anesth Prog       Date:  1985 Sep-Oct

Review 6.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

7.  Diltiazem and verapamil: functional antagonism of exogenous noradrenaline and angiotensin II in man.

Authors:  D Magometschnigg; H Hörtnagl; H Rameis
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Cooperation of augmented calcium sensitization and increased calcium entry contributes to high blood pressure in salt-sensitive Dahl rats.

Authors:  Josef Zicha; Michal Behuliak; Anna Vavřínová; Zdenka Dobešová; Jaroslav Kuneš; Hana Rauchová; Ivana Vaněčková
Journal:  Hypertens Res       Date:  2021-04-19       Impact factor: 3.872

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.